Search

10X Genomics Inc (Class A)

Closed

SectorHealthcare

47.13 8.87

Overview

Share price change

24h

Current

Min

41.85

Max

44.08

Key metrics

By Trading Economics

Income

2.8M

-13M

Sales

-15M

151M

EPS

0.07

Profit margin

-8.93

Employees

1,178

EBITDA

19M

-937K

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-11.57% downside

Dividends

By Acuity

Next Earnings

6 Aug 2026

Market Stats

By TradingEconomics

Market Cap

2.5B

5.3B

Previous open

38.26

Previous close

47.13

News Sentiment

By Acuity

100%

0%

319 / 340 Healthcare

10X Genomics Inc (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

20 Jul 2026, 19:16 UTC

News
Correlated Moves

10X Genomics Inc. shares are lower as a report cites only 1.1% annual sales growth and ineffective growth strategies amid a declining Life Sciences Tools sector.

Peer Comparison

Price change

10X Genomics Inc (Class A) Forecast

Price Target

By TipRanks

-11.57% downside

12 Months Forecast

Average 38.22 USD  -11.57%

High 50 USD

Low 20 USD

Based on 11 Wall Street analysts offering 12 month price targets for10X Genomics Inc (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

3

Buy

8

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
help-icon Live chat